EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark QIAGEN - Sample to Outcome was filed as Word mark on 11/30/2018 at the European Union Intellectual Property Office.
It was registered as a trademark on 05/15/2019.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 017995107 |
| Application date | November 30, 2018 |
| Publication date | February 5, 2019 |
| Entry date | May 15, 2019 |
| Expiration date | November 30, 2028 |
Trademark owner
Qiagen Str. 1
40724 Hilden
DE
40724 Hilden
DE
Trademark representatives
Kaiserstraße 100
52134 Herzogenrath
DE
goods and services
9
Computer software; Computer software and related databases for use in nucleic acid and protein assay analysis and for quality control, validation, interpretation, reporting, clinical decision support, data management, integration with medical records, physician portals, laboratory networking, professional healthcare and trial matching services all related to molecular and genomic analysis; Computer Software, namely evidence-based decision support software used as an aid in the interpretation of variants observed in genomic sequencing data; Computer Software for evaluation of genomic variants in the context of published biomedical literature, professional association guidelines, publicly available databases and annotations, drug labels, and/or clinical-trials; Computer software for bioinformatics analyses, optionally combined with data management, graphical viewing and output options; Computer programs and software for biological data mining; Computer programs and software for developing bioinformatics database for others; Bio-chips for research or scientific purposes; DNA-Chips; RNA-Chips; next-generation sequencing (NGS) data processor; bioinformatics data processor; Online non-downloadable software for use in bioinformatics, genomics, phenomics, microbiome, and metagenomics applications; Computer hardware and software for collecting, storing, analyzing, visualizing, and interpreting bioinformatics, genomics, and phenomics data sets; computer hardware and software for the monitoring of pathogens; computer hardware and software for receiving, processing, transmitting and displaying associated genomics and phenomics data; computer databases for bioinformatics, genomics, phenomics, microbiome, metagenomics, organism-and -pathogen-specific genotype records, and organism and pathogen-specific phenotype information; Computer software for use in the integration, analysis and visualization of biomedically relevant information allowing users to explore compound, target, assay, biological pathway and disease information; Computer Software and databases for the analysis of genomes, exomes, targeted amplicons, transcriptomes, and epigenetic NGS sequencing data; Computer software, tools, and visualization modules, for analysis, discovery, verification, and validation of disease biomarkers
10
Medical diagnostic testing instruments for processing and analysis of genetic samples primarily for single-cell genomic, transcriptomic, or proteomic analysis; Medical and diagnostic apparatus for tests, using gene expression tests, gene expression profiling assays, genetic information and data, protein biomarkers, clinical data, and/or demographic information; Medical test apparatus each using bioinformatics and machine learning algorithms and medical data to aid treatment decisions; Medical tests apparatus quantifying biomarker levels and relative expression of host response genes; Medical apparatus and instruments for detecting tumor cancer, heredity and genetic diseases; Testing apparatus for samples of body fluids, tissue and organ; Genome machine for medical purposes; Diagnostic apparatus for the detection of cancer, genetic or heredity diseases
42
Providing temporary use of online non-downloadable software for use in bioinformatics, genomics, phenomics, microbiome, and metagenomics applications; Providing online computer databases for bioinformatics, genomics, phenomics, microbiome, metagenomics, organism- and pathogenspecific genotype records, and organism and pathogen-specific phenotype information; providing consulting services for acquiring, creating, sharing, managing, mining, analyzing, visualizing, interpreting and applying genomics and phenomics datasets; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's disease profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; Providing temporary use of on-line nondownloadable software and applications for genome analysis, developing personal treatment strategies for patients with diagnosed cancer and other diseases or disorders; conducting early evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; providing medical and bioinformatic data and scientific research information to enable physicians and healthcare professionals to optimize treatment in clinical practice; Services for the preparation of medical reports, namely creating, sharing, managing, mining, analyzing, visualizing, interpreting and applying genomics and phenomics datasets; scientific research services, namely, collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from patients with cancer and other diseases and disorders
44
Medical information retrieval and medical consulting in the fields of retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies; medical consulting services in the fields of health, medical care, biotechnology, bioinformatics, life sciences, pharmaceuticals and medicine; providing medical information in the fields of health, healthcare, life sciences, biotechnology, pharmaceuticals and pharmaceutical safety, bioinformatics, and genetic testing for medical purposes; medical consulting services with respect to the treatment and diagnosis of individuals; providing medical information on drug safety and drug compatibility in relation to therapy and the treatment of individuals; medical consulting services in the fields of diagnostics and patient treatment and treatment protocols; consulting services in the field of genomics and biological sequence processing and analysis for medical diagnosis and treatment purposes; providing medical information for the purposes of medical diagnosis and treatment in the field of molecular genetics; identification and testing of DNA samples for health care purposes; health care services, namely, genomics and data science to provide optimal health and disease prevention or treatment to patients; providing an online resource center featuring personalized health information based on genetic information and diagnostics; bioinformatics analysis for medical diagnostic and personalized treatment purposes; nucleic acid analysis and screening for medical diagnostic and treatment purposes
ID: 11017995107